Company
Gate2Brain
- Biotech
- Location:
- Barcelona (Barcelona, Spain)
Description
Gate2Brain develops peptide-based delivery technologies that transport therapeutics across biological barriers for applications including CNS and rare pediatric solid tumor treatments for biotech and clinical customers.
Related
Cleara BiotechCleara Biotech develops peptide-based therapeutics and biomarkers to selectively eliminate p53-impaired cancer cells, producing D-amino…
Intelligent TherapeuticsIntelligent Therapeutics engineers novel antibodies and antibody-like molecules for treating solid tumors and rare autoimmune diseases,…
ThelperThelper develops first-in-class antiviral antibody drug conjugates (ADCs) targeting virally encoded biomarkers in aggressive solid tumors…
Cumulus NeuroscienceCumulus Neuroscience provides a platform for monitoring brain function with digital and neurophysiological measures.
Iovance Biotherapeutics ($IOVA)Iovance Biotherapeutics develops and manufactures tumor-infiltrating lymphocyte (TIL) cell therapies for treating solid tumors, running…
EnzyTagEnzyTag develops peptiligase-based synthetic routes for manufacturing peptide-based new chemical entities, small proteins and…
Legend Biotech ($LEGN)Legend Biotech develops CAR-T cell therapies targeting blood cancers and solid tumors, advancing cellular research to expand treatment…
TassoTasso provides needle-free blood collection devices and kits for dried blood collection, prescreening, population pharmacokinetics,…
NETRIS PHARMANETRIS PHARMA develops therapeutics that target Netrin-1 to overcome resistance to chemotherapy, targeted therapy and immunotherapy,…
Generate:BiomedicinesGenerate:Biomedicines designs and engineers therapeutic proteins and cell therapies by combining machine learning with biological…
STORM TherapeuticsSTORM Therapeutics discovers and develops small-molecule drugs that modulate RNA modifying enzymes to reprogram cells for treatments in…
XENOTHERAXENOTHERA develops glyco-humanized antibody therapeutics and related immunological treatments for clinical use, pursuing products in…